Latest Case Studies

    Jul 10, 2023

    Process development: replicating the final cell therapy product

    Disease-state leukopaks are effective surrogates for establishing cell therapy manufacturing parameters.

    Jul 05, 2023

    Isolating rare cell types from peripheral blood

    Leukopaks from patients provide large pools of PBMCs.

    May 20, 2023

    Expanding the reach of clinical trials

    Immunogenicity biomarkers in individuals previously infected with COVID-19 were used to evaluate vaccines in preclinical and clinical trials.

    Apr 24, 2023

    Linking a drug mechanism to a human disease

    A specific autoimmune indication was identified for a novel therapy using patient donor biospecimens.

    Mar 24, 2023

    Describing the patient experience in biomarkers

    A prospective, longitudinal study using in-home collected biospecimens identified a panel of predictive biomarkers.


Subscribe to our Newsletter

Select what you would like to receive directly in your email